source
- STAT+: Synthetic biology researchers think they’ve made a cell. Is it alive?Researchers have created what they say may count as the first synthetic cell, and have started a public benefit corporation to share the technology with other scientists. It’s a piece…STAT · 27d ago↗ source
- Ipsen to buy Swiss biotech Memo Therapeutics in potential $800M dealThe purchase hands Ipsen an experimental medicine in late-stage testing for a virus that often affects kidney transplant patients.BioPharma Dive · 27d ago↗ source
- STAT+: Pharmalittle: We’re reading about Anthropic drug development goals, Trump drug plan snags, and moreAnthropic announced the availability of Claude Science, which optimizes its large language model for use in scientific labs and by drugmakersSTAT